This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Deutsches Krebsforschungszentrum. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Xavier Allaume: Innovator in Cancer Therapy
Introduction
Xavier Allaume is a notable inventor based in Montreuil, France. He has made significant contributions to the field of cancer therapy through his innovative research and patents. His work focuses on the genetic engineering of viruses for therapeutic purposes.
Latest Patents
Xavier Allaume holds a patent titled "Retargeting of rat parvovirus H-1PV to cancer cells through genetic engineering of its capsid." This patent describes a parvovirus, specifically H-1PV, that can be genetically retargeted through modifications to its capsid. This innovation is particularly useful in cancer therapy, offering new avenues for treatment.
Career Highlights
Xavier Allaume is affiliated with the Deutsches Krebsforschungszentrum, a leading cancer research center. His work there has been instrumental in advancing the understanding of viral therapies in oncology. His research has garnered attention for its potential to improve cancer treatment outcomes.
Collaborations
Xavier has collaborated with notable colleagues, including Antonio Marchini and Nazim El-Andaloussi. These partnerships have enriched his research and contributed to the development of innovative therapeutic strategies.
Conclusion
Xavier Allaume's contributions to cancer therapy through his patent and research at the Deutsches Krebsforschungszentrum highlight his role as a key innovator in the field. His work continues to inspire advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile